BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22992305)

  • 1. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
    Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
    Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.
    Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C
    Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Massarenti L; Enevold C; Damgaard D; Ødum N; Garred P; Frisch M; Shelef MA; Jacobsen S; Nielsen CH
    Front Immunol; 2021; 12():707690. PubMed ID: 34733271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of the PADI4 gene polymorphism and HLA-DRB1 shared epitope alleles with rheumatoid arthritis].
    Fan LY; Zong M; Lu TB; Yang L; Ding YY; Ma JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):57-61. PubMed ID: 19199253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
    Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
    Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
    Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
    Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study.
    Suzuki T; Ikari K; Yano K; Inoue E; Toyama Y; Taniguchi A; Yamanaka H; Momohara S
    PLoS One; 2013; 8(4):e61045. PubMed ID: 23577190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
    Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
    Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
    Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
    Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
    Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
    Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
    Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
    Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
    Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.
    Burr ML; Naseem H; Hinks A; Eyre S; Gibbons LJ; Bowes J; Wilson AG; Maxwell J; Morgan AW; Emery P; Steer S; Hocking L; Reid DM; Wordsworth P; Harrison P; Thomson W; Worthington J; ; ; Barton A
    Ann Rheum Dis; 2010 Apr; 69(4):666-70. PubMed ID: 19470526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.
    Snir O; Gomez-Cabrero D; Montes A; Perez-Pampin E; Gómez-Reino JJ; Seddighzadeh M; Klich KU; Israelsson L; Ding B; Catrina AI; Holmdahl R; Alfredsson L; Klareskog L; Tegnér J; Gonzalez A; Malmström V; Padyukov L
    Arthritis Res Ther; 2014 Aug; 16(4):414. PubMed ID: 25138370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.
    Cheng J; Zhang H; Zhuang C; Liu R
    J Rheumatol; 2012 Jun; 39(6):1159-65. PubMed ID: 22505706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
    Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
    Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.
    Gandjbakhch F; Fajardy I; Ferré B; Dubucquoi S; Flipo RM; Roger N; Solau-Gervais E
    J Rheumatol; 2009 May; 36(5):881-6. PubMed ID: 19332633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.